Profile of crizanlizumab and its potential in the prevention of pain crises in sickle cell disease: evidence to date.
J Blood Med. 2019 Aug 30;10:307-311. doi: 10.2147/JBM.S191423. eCollection 2019.
J Blood Med. 2019.
PMID: 31507334
Free PMC article.